ABI Licenses Exiqon's Locked Nucleic Acid IP | GenomeWeb

ABI Licenses Exiqon's Locked Nucleic Acid IP

Nov 15, 2007

NEW YORK (GenomeWeb News) – Exiqon has granted Applied Biosystems a license to use its locked nucleic acids intellectual property in siRNA projects, the Danish company said today.

Exiqon said the agreement fulfills one of its strategic goals for 2008, which was to license its LNA technology to a “major tool provider.” The company said the IP “offers many more possibilities for developing competitive products” than it has the means to pursue.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Keep on Brushing

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Panda Gut Seasonality

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

This Week in PLOS

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.